|
UBQLN4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.776700E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.075700E-02 |
| Normal-vs-Stage2 |
6.076400E-02 |
| Normal-vs-Stage3 |
1.880110E-02 |
| Normal-vs-Stage4 |
7.005600E-02 |
| Stage1-vs-Stage2 |
3.360200E-01 |
| Stage1-vs-Stage3 |
9.781700E-02 |
| Stage1-vs-Stage4 |
6.379900E-02 |
| Stage2-vs-Stage3 |
4.047400E-01 |
| Stage2-vs-Stage4 |
3.941000E-01 |
| Stage3-vs-Stage4 |
9.287600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.556120E-04 |
| Normal-vs-AfricanAmerican |
1.884610E-01 |
| Normal-vs-Asian |
8.899600E-01 |
| Caucasian-vs-AfricanAmerican |
1.362310E-02 |
| Caucasian-vs-Asian |
2.575400E-01 |
| AfricanAmerican-vs-Asian |
5.084400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.640550E-03 |
| Normal-vs-Female |
9.369300E-04 |
| Male-vs-Female |
1.886430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.888000E-02 |
| Normal-vs-Extreme_Weight |
1.869000E-01 |
| Normal-vs-Obese |
7.041500E-04 |
| Normal-vs-Extreme_Obese |
3.957200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.605000E-01 |
| Normal_Weight-vs-Obese |
2.218600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.092600E-01 |
| Extreme_Weight-vs-Obese |
1.096430E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.005200E-01 |
| Obese-vs-Extreme_Obese |
4.347400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.384900E-03 |
| Normal-vs-Age(41-60Yrs) |
1.864740E-03 |
| Normal-vs-Age(61-80Yrs) |
3.036600E-03 |
| Normal-vs-Age(81-100Yrs) |
8.620500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.002100E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.976400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.779200E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.446800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.277600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.455870E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.398400E-04 |
| Normal-VS-Type2 PRCC |
3.006000E-01 |
| Normal-VS-KIRP CIMP |
2.863200E-03 |
| Normal-VS-Unclassified PRCC |
1.508480E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.732100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.147710E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.920400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.73924999999908E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
1.514010E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.153300E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.804400E-01 |
| Normal-vs-N1 |
2.638600E-03 |
| Normal-vs-N2 |
4.744400E-02 |
| N0-vs-N1 |
6.439800E-03 |
| N0-vs-N2 |
8.606800E-04 |
| N1-vs-N2 |
5.227800E-01 |
|
|
